Literature DB >> 3704902

Surgical treatment for carcinoma at the confluence of the major hepatic ducts.

Y Iwasaki, T Okamura, A Ozaki, T Todoroki, Y Takase, K Ohara, A Nishimura, H Otsu.   

Abstract

During the period of November 1976 through October 1984, we have treated 46 patients with carcinoma at the confluence of the major hepatic ducts. Curative resection of the tumor (where no carcinoma cells at the margin of the resected portion were found macroscopically and microscopially), was performed upon ten patients, palliative resections were done in 11, palliative resection and intraoperative radiotherapy (IOR) in ten, bile duct drainage and IOR in three, and percutaneous transhepatic cholangiodrainage in 12. Among the ten patients who underwent curative operation, five are living six to 104 months after operation while the remaining five died four to 72 months postoperatively. Of the 11 patients who underwent palliative resection, five are alive two to 22 months after operation and six died between four and 20 months after operation. For the ten patients with carcinoma in the advanced stages, palliative resection with IOR was performed. Eight patients died 20 days to 16 months after operation while two patients are alive 13 and 14 months after the procedure. Of the three patients who underwent drainage of the bile duct and IOR, two died three months after operation and one patient survived 34 months. Twelve patients underwent drainage of the bile duct only and all died after 13 months. To perform a curative operation for carcinoma located at the confluence of major hepatic ducts, it is necessary to resect the right or left lobe, including the caudate lobe, in many instances. For the patients with carcinoma in the advanced stages, the possibility of long term survival period after operation exists through the use of the combined techniques of IOR and palliative resection of the tumor.

Entities:  

Mesh:

Year:  1986        PMID: 3704902

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  13 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Retrograde portography of the right caudate lobe via the middle hepatic vein.

Authors:  J Kamiya; M Nagino; Y Nimura
Journal:  Surg Radiol Anat       Date:  2003-11-25       Impact factor: 1.246

Review 3.  Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.

Authors:  Saleh Abbas; Charbel Sandroussi
Journal:  HPB (Oxford)       Date:  2013-01-08       Impact factor: 3.647

4.  Proximal bile duct cancer: high resectability rate and 5-year survival.

Authors:  B Launois; J Terblanche; M Lakehal; J M Catheline; E Bardaxoglou; S Landen; J P Campion; F Sutherland; B Meunier
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

5.  [Surgical therapy of proximal bile duct cancer].

Authors:  B Teleky; J M Funovics; F Herbst; A Fritsch
Journal:  Langenbecks Arch Chir       Date:  1991

6.  Percutaneous transhepatic endoprosthesis in malignant obstruction of the bile duct.

Authors:  T Yamakawa; R D Esguerra; H Kaneko; E Fukuma
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

7.  Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer.

Authors:  C W Pinson; R L Rossi
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

8.  The role of intraoperative radiation therapy in the treatment of bile duct cancer.

Authors:  Y Iwasaki; T Todoroki; K Fukao; K Ohara; T Okamura; A Nishimura
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

9.  Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer.

Authors:  R Pichlmayr; B Ringe; W Lauchart; W O Bechstein; G Gubernatis; E Wagner
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

10.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.